- Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20% CNBC
- Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing Yahoo Finance
- Novo Nordisk ends collaboration with Hims & Hers over weight loss drug sale Reuters
- Novo Exits Hims & Hers Partnership, Citing Compounding Concerns Bloomberg.com
- Novo Nordisk ends deal with Hims due to compounding concerns with obesity drugs STAT
